Introduction {#section1-2050312116673855}
============

Lung cancer is the leading cause of cancer death in males, and in females, its mortality burden is as high as cervical cancer.^[@bibr1-2050312116673855]^ In 2012, an estimated 1.8 million people were diagnosed with lung cancer, resulting in 1.6 million deaths.^[@bibr2-2050312116673855]^ Lung cancer is the leading malignant cause of death in 93 countries, accounting for one-fifth of the total global burden of disability-adjusted life years from cancer.^[@bibr2-2050312116673855]^ Non-small cell lung cancer (NSCLC)^[@bibr2-2050312116673855]^ comprises 85% of all lung cancers. Up to 63% of patients diagnosed with lung cancer also present chronic obstructive pulmonary disease (COPD).^[@bibr3-2050312116673855]^ If we consider all stages of NSCLC, the prognosis is poor, with an overall 5-year survival rate of 15%.^[@bibr4-2050312116673855]^ Lobectomy for initial stages demonstrates higher survival rates, but only 15%−25% of patients are surgical candidates because of cardiopulmonary impairment due to coexisting COPD. Therefore, patients undergo medical treatment or marginal lung resection, with minor functional impact but possible ineffective control of disease.^[@bibr5-2050312116673855][@bibr6-2050312116673855]--[@bibr7-2050312116673855]^ Furthermore, coexisting COPD is associated with increased postoperative morbidity and mortality.^[@bibr5-2050312116673855],[@bibr6-2050312116673855]^

Improvements in early diagnosis and surgical techniques have increased post-surgery survival rates. Therefore, in recent years, there has been a growing interest towards interventions that aim at improving health-related quality of life (HRQoL) and lessening morbidity for patients affected by lung cancer, either before or after surgery.^[@bibr8-2050312116673855],[@bibr9-2050312116673855]^

'Pulmonary Rehabilitation (PR) is a comprehensive intervention based on a thorough patient assessment followed by patient-tailored therapies, that include, but are not limited to, exercise training, education and behaviour change designed to improve physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviours'.^[@bibr10-2050312116673855]^ PR goals include minimising symptom burden, maximising exercise performance, promoting autonomy, increasing participation in everyday activities, enriching HRQoL and influencing long-term health-enhancing behaviour change.^[@bibr7-2050312116673855],[@bibr10-2050312116673855]^ It is widely recognised that physical exercise is the cornerstone in PR programmes.^[@bibr11-2050312116673855]^

It has been shown that preoperative PR ameliorates functional parameters that establish operability in COPD patients; therefore, candidates for surgery could benefit from this functional improvement in terms of larger possible lung resection and lower incidence of postoperative complications.^[@bibr7-2050312116673855],[@bibr11-2050312116673855]^

Recent guidelines by Spruit et al.^[@bibr10-2050312116673855]^ highlight findings of uncontrolled trials reporting that PR after lung resection surgery improves walking endurance and peak exercise capacity, while reducing dyspnoea and fatigue. Likewise, postoperative PR significantly improves respiratory function and exercise capacity in treated patients, but the effect on long-term functioning and HRQoL is still under debate.^[@bibr10-2050312116673855],[@bibr12-2050312116673855]^ Nonetheless, exercise training during cancer treatment has demonstrated to be safe, feasible and associated with significant improvement in exercise capacity, symptoms and some domains of HRQoL.^[@bibr7-2050312116673855],[@bibr9-2050312116673855],[@bibr13-2050312116673855],[@bibr14-2050312116673855]^

Furthermore, it has been confirmed that peak oxygen consumption is a strong independent predictor of overall long-term survival for individuals with NSCLC, while low exercise tolerance is associated with poor thoracic surgical outcomes.^[@bibr10-2050312116673855],[@bibr15-2050312116673855]^

Lung cancer is one of the most prevalent types of cancer and research that investigates effects of exercise intervention or aims at developing PR programmes specific to these patients is increasing. However, optimal design of exercise intervention, tailored to lung cancer patients, either pre- or post-surgery, has yet to be established.^[@bibr9-2050312116673855],[@bibr13-2050312116673855]^

In recent years, Crandall et al.^[@bibr9-2050312116673855]^ have published a systematic review of literature regarding effectiveness of exercise in patients surgically treated for NSCLC, either pre- or post-surgery. Crandall et al.^[@bibr9-2050312116673855]^ concluded that there is insufficient evidence to design the most suitable exercise intervention for patients surgically treated for NSCLC, suggesting that higher quality randomised controlled trials (RCTs) are required.^[@bibr9-2050312116673855]^

Furthermore, Cavalheri et al.,^[@bibr16-2050312116673855]^ in 2014, published a Cochrane review about the effects of postoperative exercise training in NSCLC patients. The authors concluded that exercise training may potentially increase physical capacity of individuals following surgery, but their results should be interpreted with caution due to disparities of studies, methodologic limitations, significant risk of bias and small sample sizes of clinical trials analysed in that review.^[@bibr16-2050312116673855]^

Our final aim is to define and implement the most updated and evidence-based physical exercise interventions directed at patients surgically treated for NSCLC, both pre- and post-surgery. These programmes will become part of an experimental intervention in a future clinical trial designed to investigate the effects of physical therapy on surgical candidates with lung cancer.

The Cochrane Collaboration recommends periodic updating of literature search (e.g. every 2 years) to determine whether any new relevant information is available.^[@bibr17-2050312116673855]^ Thus, considering the good methodological quality of the previous systematic review of Crandall et al.^[@bibr9-2050312116673855]^ and similarities with the objectives this study, we have chosen to update their review and to take into consideration the previous results of Cavalheri et al.^[@bibr16-2050312116673855]^

Accordingly, we have carried out this systematic review, examining the best evidence regarding PR, focusing mainly on the physical training component for preoperative and postoperative interventions in patients with lung cancer undergoing surgery.

Materials and methods {#section2-2050312116673855}
=====================

We searched the following databases from May 2013 to May 2016:

-   MEDLINE;

-   EMBASE;

-   CINAHL;

-   Cochrane Library;

-   PsycINFO.

The search strategy is reported in [Appendix 1](#app1-2050312116673855){ref-type="app"} and is identical to the strategy used by Crandall et al.^[@bibr9-2050312116673855]^ up to May 2013.

Inclusion criteria {#section3-2050312116673855}
------------------

Studies were included in the review according to the following criteria:

1.  *Population.* Trials that included participants who underwent surgery for NSCLC with curative intent. We excluded trials which included patients who underwent exclusively chemotherapy and/or radiotherapy because of the impact of these therapies would have on outcome measures and different prognosis of this population.

2.  *Intervention.* Any supervised or unsupervised, inpatient or outpatient or home-based PR exercise-training programme. The exercise programme had to be described in sufficient detail in order to be reproducible.

3.  *Outcome measures.* Exercise capacity, lung function, HRQoL and postoperative pulmonary complications (PPCs).

4.  *Methodology.* Since this study investigates treatment efficacy, only RCTs were searched.

5.  *Language.* Reports published in English, French, Italian, Portuguese and Spanish.

Study selection {#section4-2050312116673855}
---------------

Two reviewers (P.F.S.R., C.M.) reviewed all the records retrieved in order to check for inclusion criteria. They preliminarily screened titles and abstracts and then retrieved and analysed the full text of studies judged appropriate for study purposes. In case of disagreement, the opinion of a third reviewer was asked (S.C.).

Assessment of methodological quality {#section5-2050312116673855}
------------------------------------

Two reviewers (P.F.S.R., C.M.) assessed methodological quality of each study according to the Cochrane Collaboration risk of bias tool.^[@bibr18-2050312116673855]^ In case of disagreement, the opinion of a third reviewer was asked (S.C.).

Data extraction {#section6-2050312116673855}
---------------

For every RCT included, two reviewers (P.F.S.R., C.M.) extracted the following data:

-   Participants: gender, age, type of surgery;

-   Intervention: type of exercise, intensity, length of intervention, duration of session, frequency, supervision (provided/not provided), individual versus group session, inpatient versus outpatient and/or home-based regimen;

-   Outcome measures collected;

-   Results.

When essential data were missing, the investigators requested them from authors.

Results {#section7-2050312116673855}
=======

Bibliographic search results {#section8-2050312116673855}
----------------------------

We retrieved 556 references without duplicates. After preliminary review of titles and abstracts, we excluded 461 studies because their main subject was not related to our research question, 68 because they did not meet inclusion criteria, 5 because they were already present in the review by Crandall et al.^[@bibr9-2050312116673855]^ and 1 study because only protocol was published.^[@bibr19-2050312116673855]^ Of the remaining 21 studies, 2 were editorials^[@bibr20-2050312116673855],[@bibr21-2050312116673855]^ and 5 were published as abstracts^[@bibr22-2050312116673855][@bibr23-2050312116673855][@bibr24-2050312116673855][@bibr25-2050312116673855]--[@bibr26-2050312116673855]^ and therefore data were not complete. Regarding these abstracts, two^[@bibr22-2050312116673855],[@bibr26-2050312116673855]^ were excluded because they were already included as full texts^[@bibr27-2050312116673855],[@bibr28-2050312116673855]^ in our initial bibliographic research. Concerning the three remaining abstracts, we contacted the corresponding authors in order to obtain complete data. In one case,^[@bibr25-2050312116673855]^ the authors provided the requested data, whereas in the other two cases, our attempts were unsuccessful.^[@bibr22-2050312116673855],[@bibr23-2050312116673855]^ Consequently, we analysed 15 studies. Upon reading the full text, nine studies were excluded from our review because they did not meet inclusion criteria: six studies were not RCTs,^[@bibr29-2050312116673855][@bibr30-2050312116673855][@bibr31-2050312116673855][@bibr32-2050312116673855][@bibr33-2050312116673855]--[@bibr34-2050312116673855]^ two studies did not entirely focus on patients who underwent surgery for NSCLC, as it also included patients receiving exclusively chemotherapy and/or radiotherapy,^[@bibr35-2050312116673855],[@bibr36-2050312116673855]^ and one study^[@bibr28-2050312116673855]^ because it was only a feasibility study and was not focused on the effectiveness of exercise training. Therefore, six RCTs were included in this review.^[@bibr8-2050312116673855],[@bibr25-2050312116673855],[@bibr27-2050312116673855],[@bibr37-2050312116673855][@bibr38-2050312116673855]--[@bibr39-2050312116673855]^ The flow chart representing selection process of studies is reported in [Figure 1](#fig1-2050312116673855){ref-type="fig"}.

![Flow chart of study selection.](10.1177_2050312116673855-fig1){#fig1-2050312116673855}

Characteristics of included studies {#section9-2050312116673855}
-----------------------------------

The included studies were parallel RCTs and participants were randomised into an experimental intervention group (IG) or control group (CG).

One of the included studies focused on preoperative PR,^[@bibr37-2050312116673855]^ while the other five focused on postoperative PR.^[@bibr8-2050312116673855],[@bibr25-2050312116673855],[@bibr27-2050312116673855],[@bibr38-2050312116673855],[@bibr39-2050312116673855]^ Detailed study characteristics are presented in [Table 1](#table1-2050312116673855){ref-type="table"}.

###### 

Study characteristics.

![](10.1177_2050312116673855-table1)

  Reference                                       PRE/POST intervention   Patients   Type of surgery                 Demographic characteristics of patients   
  ----------------------------------------------- ----------------------- ---------- ------------------------------- ----------------------------------------- -------------
  Stefanelli et al.^[@bibr37-2050312116673855]^   PRE                     40         100% thoracotomy                65.5 ± 7.4                                64.8 ± 7.3
  Arbane et al.^[@bibr39-2050312116673855]^       POST                    131        70.3% thoracotomy, 29.7% VATS   67 ± 11                                   68 ± 11
  Brocki et al.^[@bibr8-2050312116673855]^        POST                    78         76.9% thoracotomy, 23.1% VATS   64 ± 10                                   65 ± 9
  Edvardsen et al.^[@bibr38-2050312116673855]^    POST                    61         83.6% thoracotomy, 16.4% VATS   64.4 ± 9.3                                65.9 ± 8.5
  Cavalheri et al.^[@bibr25-2050312116673855]^    POST                    17         47% thoracotomy, 53% VATS       66 ± 10                                   68 ± 9
  Hoffman et al.^[@bibr27-2050312116673855]^      POST                    87         90% thoracotomy, 10% VATS       67.4 ± 9.7                                65.6 ± 10.1

PRE: preoperative; POST: postoperative; SD: standard deviation; IG: intervention group; CG: control group; VATS: video-assisted thoracoscopic surgery.

Participants {#section10-2050312116673855}
------------

The sample size of preoperative trial consisted of 40 participants with an average age of 65 ± 7 years.^[@bibr37-2050312116673855]^ Overall, the five postoperative trials included 374 participants (range, 17--131); 191 were randomised into the experimental IG and 183 into the control one. In all, 278 of the 374 randomised patients completed follow-up (74.3%). Follow-up took place at different time points: at 4 weeks after surgery,^[@bibr39-2050312116673855]^ at 6 weeks after surgery,^[@bibr27-2050312116673855]^ at 8 weeks after baseline assessment,^[@bibr25-2050312116673855]^ at 20 weeks after intervention^[@bibr38-2050312116673855]^ and 1 year after the baseline assessment.^[@bibr8-2050312116673855]^ In all, 139 of these follow-up patients were allocated to the IG and 139 to the control one. Studies recruited both males and females, and average age of participants was 66 ± 10 years.

Methodologic quality {#section11-2050312116673855}
--------------------

Methodologic quality of the included studies is reported in [Figures 2](#fig2-2050312116673855){ref-type="fig"} and [3](#fig3-2050312116673855){ref-type="fig"}.

![Risk of bias analysis of preoperative study.](10.1177_2050312116673855-fig2){#fig2-2050312116673855}

![Risk of bias analysis of postoperative studies.](10.1177_2050312116673855-fig3){#fig3-2050312116673855}

None of the studies reported blinding of participants and personnel. Four^[@bibr8-2050312116673855],[@bibr25-2050312116673855],[@bibr27-2050312116673855],[@bibr38-2050312116673855],[@bibr39-2050312116673855]^ out of five^[@bibr27-2050312116673855]^ postoperative studies reported blinding of outcome assessors, and the preoperative study^[@bibr37-2050312116673855]^ did not report sufficient information to evaluate this aspect. However, the studies of Stefanelli et al.^[@bibr37-2050312116673855]^ and Hoffman et al.^[@bibr27-2050312116673855]^ were deemed as a low risk for detection bias, since outcomes analysed in these studies are usually measured in an objective manner. Risk of bias for included studies is reported in [Appendix 2](#app2-2050312116673855){ref-type="app"}.

Characteristics of PR programmes {#section12-2050312116673855}
--------------------------------

[Table 2](#table2-2050312116673855){ref-type="table"} summarises the characteristics of PR programmes described by the included studies.

###### 

PR programme characteristics.

![](10.1177_2050312116673855-table2)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                                             Group                                                                                                                                   Exercise type                                                                                                                           Intensity                                                                                                                                                                                                                                                                                                                              Length of intervention                     Session duration                                                                                         Frequency                                                 Supervised/unsupervised                                                               Group/individual                      Inpatient/outpatient/home-based
  ----------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------ -------------------------------------------------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------------- ------------------------------------- ----------------------------------------------------------------------------------------
  Stefanelli et al.^[@bibr37-2050312116673855]^ (PRE)   IG                                                                                                                                      • Respiratory exercises on bench, mattress pad and wall bars, respectively;\                                                            70% of the maximum score reached at CPET and increased by 10 W when the patient was able to tolerate the set load for 30 min                                                                                                                                                                                                           3 weeks                                    3 h                                                                                                      5 sessions/week                                           Supervised                                                                            Individual                            Out
                                                                                                                                                                                                • AT: upper limbs with rowing ergometer, lower limbs by means of treadmill and ergometric bicycle                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  CG                                                    • Usual care -- no exercise                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Brocki et al.^[@bibr8-2050312116673855]^ (POST)       IG                                                                                                                                      • AT: stationary bike;\                                                                                                                 • AT: RPE 11--12 (1--4 sessions); RPE 13--16 (5--10 sessions)\                                                                                                                                                                                                                                                                         10 weeks                                   15 min warm-up; 20 min aerobic exercise; 15 min muscle strength training; 10 min cool-down/relaxation\   1 session/week from 3rd week after surgery to 13th week   Supervised                                                                            Group                                 Out
                                                                                                                                                                                                • ST: arms (green Thera-band^®^), trunk (abdomen, back), legs (step-ups, heel-raises, sit-to-stands);\                                  • ST: 6--10 rep, 1--2 sets\                                                                                                                                                                                                                                                                                                                                                       Total 1 h                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                • Home exercises (strength training at least twice a week and a daily 30 m walk or bicycle ride with intensity of 11--12 RPE);\         • Home exercises: 11--12 RPE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                • Usual postoperative nurse counselling, 3 individual sessions of 1 h 30 min;\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                • Dyspnoea management techniques                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  CG                                                    • Home exercises (strength training at least twice a week and a daily 30 min walk or bicycle ride with intensity of 11--12 RPE);\       • Home exercises: 11--12 RPE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Home-based                            
                                                        • Usual postoperative nurse counselling, three individual sessions of 1 h 30 min                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Arbane et al.^[@bibr39-2050312116673855]^ (POST)      IG                                                                                                                                      • AT: bicycle;\                                                                                                                         • AT: 50--60 r/min with the intensity increased steadily during the third minute to achieve a maximum of 60%−90% of heart rate reserve and to 3 or 4 on BBS and 13--15 on RPE                                                                                                                                                          Length of hospital stay (about 5 days);\   • AT: Starting from 5 min to 30 min in total (with 2 min warm-up and 2 min cool-down)                    Daily                                                     Supervised\                                                                           Individual                            In\
                                                                                                                                                                                                • ST: 10 RM using ankle weights\                                                                                                                                                                                                                                                                                                                                                                                                                                               SPACE from discharge                                                                                                                                                                                          SPACE: unsupervised                                                                                                         SPACE: Out
                                                                                                                                                                                                • Usual care: routine physiotherapy treatments, airway clearance techniques where indicated, mobilisation and upper limb activities;\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                • At home: SPACE walking programme for people with COPD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  CG                                                    • Usual care -- routine physiotherapy treatments, airway clearance techniques where indicated, mobilisation and upper limb activities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Edvardsen et al.^[@bibr38-2050312116673855]^ (POST)   IG                                                                                                                                      • AT: walking uphill on treadmill;\                                                                                                     • AT: 80%−95% MHR;\                                                                                                                                                                                                                                                                                                                    20 weeks                                   1 h                                                                                                      • AT and ST: 3 sessions/week;\                            • AT and ST: Supervised;\                                                             2 weekly sessions individual;\        Out
                                                                                                                                                                                                • ST: progressive resistance training\                                                                                                  • ST: 3 series of 6--12 RM of leg press, leg extension, back extension, seat row, bicep curls and chest-and-shoulder press                                                                                                                                                                                                                                                                                                                                                                 • IMT: daily                                              • IMT: Unsupervised                                                                   1 weekly session group, if possible   
                                                                                                                                                                                                • IMT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  CG                                                    • Usual care -- general information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Cavalheri et al.^[@bibr25-2050312116673855]^ (POST)   IG                                                                                                                                      • AT: walking along 100-m corridor or on a treadmill, or cycle ergometer^[a](#table-fn3-2050312116673855){ref-type="table-fn"}^;\       • AT: for corridor walking initial speed set at 80% of the average 6MWT speed; for treadmill walking, initial speed set at 70% of the average 6MWT speed. Walking speed increased when participants were able to walk 20 min continuously with symptoms and SpO2 within acceptable limits (⩾88%)\                                      8 weeks                                    60 min                                                                                                   3 sessions/week                                           Supervised;\                                                                          Individual                            Out; cycle ergometer^[a](#table-fn3-2050312116673855){ref-type="table-fn"}^ home-based
                                                                                                                                                                                                • ST: step-ups (undertaken within parallel bars) and exercises with hand weights for the biceps brachii muscle and deltoid muscle       Cycle ergometer^[a](#table-fn3-2050312116673855){ref-type="table-fn"}^:10 min of endurance training (initial work rate was set at 60% of the Wmax achieved during the CPET) and two periods of 2 min of power training (initial work rate was set at 80% of the Wmax achieved during the CPET performed at the baseline assessment)\                                                                                                                                                                                                                 cycle ergometer^[a](#table-fn3-2050312116673855){ref-type="table-fn"}^ unsupervised                                         
                                                                                                                                                                                                                                                                                                                                        • ST: step-ups in 2 sets of 10 repetition; upper limb training in 3 sets of 10 repetitions (initial weights: 1.5 kg for women and 2 kg for men)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  CG                                                    • Usual care -- no exercise                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Hoffman et al.^[@bibr27-2050312116673855]^ (POST)     IG                                                                                                                                      • AT: walking in place with the Wii\                                                                                                    • AT: 5 min during week 1 and continued to build by 5 min/day each week with the goal of walking with the Wii of 30 min/day during week 6. The duration was increased by 5 min each week if the participant's PSE for attaining that duration was 70% or greater on a 0%−100% scale, with 100% having the highest PSE                  6 weeks                                    Variable: from 5 to 30 min                                                                               5 sessions/week\                                          Unsupervised                                                                          Individual                            Home-based
                                                                                                                                                                                                • Balance exercises from a menu of predetermined Wii balance exercises                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             (5 days a week for weeks 1--6)                                                                                                                                                        

                                                        CG                                                                                                                                      • Usual care -- without exercise                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IG: intervention group; CG: control group; UL: upper limb; rep: repetitions; AT: aerobic training; IMT: inspiratory muscle training; MIP: maximal inspiratory pressure; CPT: chest physical therapy; CPET: cardiopulmonary exercise test; ST: strength training; RPE: Borg rating of perceived exertion; SPACE: Self-management Programme of Activity, Coping and Education; COPD: chronic obstructive pulmonary disease; BBS: Borg CR10 Breathlessness Scale; RM: repetition maximum; MHR: maximum heart rate; 6MWT: Six-Minute Walk Test; PSE: perceived self-efficacy.

In the event that a participant could only attend two supervised sessions per week, they were provided with a cycle ergometer (OBK600A; Orbit fitness equipment, Perth, WA, Australia) to use at home for one training session per week.

### Preoperative rehabilitation programme {#section13-2050312116673855}

Regarding the preoperative PR, Stefanelli et al.^[@bibr37-2050312116673855]^ included incremental high-intensity aerobic training, both for lower and upper limbs and respiratory exercises. The PR programme lasted 3 weeks, consisting of five supervised individual sessions per week, conducted in an outpatient setting. The CG received usual care but further details were not reported.

### Postoperative rehabilitation programmes {#section14-2050312116673855}

Postoperative programmes included aerobic and strength or balance training. Regarding the respiratory component, Edvardsen et al.^[@bibr38-2050312116673855]^ included inspiratory muscle training (IMT), Arbane et al.^[@bibr39-2050312116673855]^ incorporated routine physiotherapy treatments and Brocki et al.^[@bibr8-2050312116673855]^ incorporated dyspnoea management techniques.

The intervention described by Hoffman et al.^[@bibr27-2050312116673855]^ was a 6-week, home-based, unsupervised, walking and balance exercise programme using Nintendo Wii Fit Plus. The walking programme started off at 5 min/day for the first 5 days in week 1. Duration was increased every week in order to reach the goal of continuous walking for 30 min/day by week 6. Participants also performed a series of programmed balance exercises 5 days a week from week 1 to week 6. The CG performed usual care and was not given any advice concerning exercise.

The intervention programme of Cavalheri et al.^[@bibr25-2050312116673855]^ consisted in an 8-week individual, supervised, inpatient training 3 days/week comprising aerobic and resistance training. If some participants could only attend two supervised sessions per week, they were provided with a cycle ergometer (OBK600A; Orbit fitness equipment, Perth, WA, Australia) to use at home for one training session per week. The CG was instructed to continue performing their usual activities; in addition, they received weekly phone calls from a research assistant who asked them general questions about their health and well-being.

The intervention described by Edvardsen et al.^[@bibr38-2050312116673855]^ was a 20-week, high-intensity programme consisting of three outpatient sessions per week, one being a group session, when possible. Aerobic and strength training were supervised, whereas IMT was unsupervised and performed daily. CG performed usual care and was not given any advice regarding exercise, besides routine general information.

The intervention programme of Arbane et al.^[@bibr39-2050312116673855]^ consisted first in daily inpatient sessions, lasting about 5 days, up to discharge; after that, patients initiated Self-Management Programme of Activity, Coping and Education (SPACE) in an unsupervised and outpatient setting. The CG received usual care including routine physiotherapy treatments, airway clearance techniques, mobilisation and upper limb activities.

The intervention programme of Brocki et al.^[@bibr8-2050312116673855]^ consisted of weekly group rehabilitation sessions lasting 10 weeks, starting from the third post-surgery week. Sessions were supervised in an outpatient setting. This programme also included three individual sessions of postoperative nurse counselling, lasting one and a half hours, as part of usual care provided for both groups. Furthermore, the CG was given a home-based exercise programme including aerobic and strength training.

Outcome measures {#section15-2050312116673855}
----------------

[Table 3](#table3-2050312116673855){ref-type="table"} summarises outcome measures analysed in included studies.

###### 

Outcome measures.

![](10.1177_2050312116673855-table3)

  Reference                                       PRE/POST   Exercise capacity            HRQoL
  ----------------------------------------------- ---------- ---------------------------- ---------------------------------
  Stefanelli et al.^[@bibr37-2050312116673855]^   PRE        VO~2~ peak (CPET)            
  Hoffman et al.^[@bibr27-2050312116673855]^      POST       6MWT                         SF-36
  Cavalheri et al.^[@bibr25-2050312116673855]^    POST       6MWT and VO~2~ peak (CPET)   SF-36 + FACT-L + EORTC QOL C-30
  Edvardsen et al.^[@bibr38-2050312116673855]^    POST       VO~2~ peak (treadmill)       SF-36 + EORTC QOL C-30 dyspnoea
  Arbane at al.^[@bibr39-2050312116673855]^       POST       ISWT                         SF-36 + EORTC QOL-LC13
  Brocki et al.^[@bibr8-2050312116673855]^        POST       6MWT                         SF-36

PRE: preoperative; POST: postoperative; HRQoL: health-related quality of life; CPET: cardiopulmonary exercise test; 6MWT: Six-Minute Walk Test; SF-36: Short Form 36; FACT-L: Functional Assessment of Cancer Therapy -- Lung scale; EORTC QOL: European Organisation for Research and Treatment of Cancer Quality Of Life; ISWT: Incremental Shuttle Walk Test.

### Preoperative study {#section16-2050312116673855}

Exercise capacity was analysed by Stefanelli et al.^[@bibr37-2050312116673855]^ by means of VO~2peak~ (maximum consumption of O~2~ at exercise peak) using the cardiopulmonary exercise test (CPET).

Regarding lung function, Stefanelli et al.^[@bibr37-2050312116673855]^ analysed forced expiratory volume in first second (FEV~1~) and diffusing lung capacity of carbon monoxide (DLCO).

### Postoperative studies {#section17-2050312116673855}

All trials measured exercise capacity. Edvardsen et al.^[@bibr38-2050312116673855]^ analysed VO~2peak~ using a continuous graded exercise protocol on a treadmill. Brocki et al.^[@bibr8-2050312116673855]^ and Hoffman et al.^[@bibr27-2050312116673855]^ used Six-Minute Walk Test (6MWT). Cavalheri et al.^[@bibr25-2050312116673855]^ used 6MWT and VO~2peak~ performing also CPET. Arbane et al.^[@bibr39-2050312116673855]^ measured exercise capacity with Incremental Shuttle Walk Test (ISWT). They also recorded activity levels with an Actiwatch that was given to patients to wear at least 48 h preoperatively and then for 5 days post-surgery (or until discharge, if earlier). Participants were given the Actiwatch again 1 week prior to the 4-week postoperative assessment and were asked to wear it for at least 5 days.

Lung function was analysed in three trials. Cavalheri et al.^[@bibr25-2050312116673855]^ analysed FEV~1~, functional vital capacity (FVC), total lung capacity and DLCO. Edvardsen et al.^[@bibr38-2050312116673855]^ reported FEV~1~ and DLCO and Brocki et al.^[@bibr8-2050312116673855]^ analysed FEV~1~ and FVC.

HRQoL was assessed through Short Form-36 questionnaire (SF-36) in all trials^[@bibr8-2050312116673855],[@bibr25-2050312116673855],[@bibr27-2050312116673855],[@bibr38-2050312116673855],[@bibr39-2050312116673855]^ and three of them also used the European Organisation for Research and Treatment of Cancer questionnaire (EORTC).^[@bibr25-2050312116673855],[@bibr38-2050312116673855],[@bibr39-2050312116673855]^ Cavalheri et al.^[@bibr25-2050312116673855]^ analysed HRQoL using also the Functional Assessment of Cancer Therapy -- Lung scale (FACT-L).

PR programme effectiveness {#section18-2050312116673855}
--------------------------

### Preoperative study {#section19-2050312116673855}

Stefanelli et al.^[@bibr37-2050312116673855]^ trial reported that differences between groups were null at baseline. Instead, at T1 (after preoperative rehabilitation and pre-surgery) and at T2 (60 days post-surgery), it showed a significant difference in VO~2peak~ between groups in favour of the IG (p \< 0.001 and p \< 0.01, respectively). Furthermore, in the IG, they observed a within-group significant improvement in VO~2peak~ from baseline to T1. This improvement was not maintained after surgery, when patients in the IG fell back to their baseline values. On the contrary, within the CG, VO~2peak~ registered a continuous decrease at both time points. Significant worsening after surgery brought this group to a level lower than baseline. Regarding lung function, this trial failed to report any between-group differences. Yet, it reported a significant within-group decrease of DLCO and FEV~1~, from baseline to T1 and from T1 to T2 for both IG and CG.

### Postoperative studies {#section20-2050312116673855}

Regarding exercise capacity, Hoffman et al.^[@bibr27-2050312116673855]^ reported a significant delta difference in distances at 6 weeks post-surgery versus pre-surgery (p \< 0.001). Cavalheri et al.^[@bibr25-2050312116673855]^ reported greater gains favouring IG for VO~2peak~ (mean difference (95% confidence interval (CI)) 0.19 (0.04--0.33) L/min), O~2~ pulse (2 (0--3) mL/beat) and anaerobic threshold (11 (1--21)% of VO~2peak~); regarding 6MWT, the authors reported greater favouring IG for distance walked (mean difference (95% CI of difference) 52 (12--93) min). Edvardsen et al.^[@bibr38-2050312116673855]^ reported a significant difference between groups in VO~2peak~ after postoperative PR (p = 0.02), favouring IG. Arbane et al.^[@bibr39-2050312116673855]^ did not clearly report exercise capacity levels measured by ISWT. We tried to contact the corresponding author to obtain complete data but our attempts were unsuccessful. Nevertheless, from data presented graphically in this study, it seems that, after postoperative PR, CG did not improve exercise capacity, whereas in IG, it improved by 60 min. However, we do not know if this difference was statistically significant. Also, using intention-to-treat analysis, they found no between or within-group significant differences for total active time, measured by Actiwatch, 4 weeks post-surgery. Brocki et al.^[@bibr8-2050312116673855]^ showed an improvement in walking distance 4 months and 1-year post-surgery in both groups, with no between-group differences at any time.

Lung function, analysed in Cavalheri et al.,^[@bibr25-2050312116673855]^ Edvardsen et al.^[@bibr38-2050312116673855]^ and Brocki et al.^[@bibr8-2050312116673855]^ trials, did not present significant changes in FEV~1~ and FVC; only DLCO, reported by Edvardsen et al.,^[@bibr38-2050312116673855]^ presented significant differences between groups after PR (p = 0.01), supporting IG.

In relation to HRQoL, the study by Hoffman et al.^[@bibr27-2050312116673855]^ showed a within-group improvement in IG after intervention for mental and physical domains of SF-36, but we cannot determine if this difference was statistically significant between groups because data were not completely reported. The study by Cavalheri et al.^[@bibr25-2050312116673855]^ reported no between-group differences in the three rating scales used. The study by Edvardsen et al.^[@bibr38-2050312116673855]^ reported significant differences between groups after intervention in both physical and mental domains of SF-36 (p = 0.006 and 0.02, respectively), supporting the experimental programme. Moreover, this trial analysed dyspnoea dominium of EORTC and found a significant improvement in IG (p = 0.03). The trial conducted by Brocki et al.^[@bibr8-2050312116673855]^ found no statistical differences between groups in any of the SF-36 domains, except for the one dealing with body pain, which revealed a statistically significant improvement favouring IG 4 months post-surgery (p = 0.01). Arbane et al.^[@bibr39-2050312116673855]^ stated no significant differences in quality of life between IG and CG, measured either by SF-36 or EORTC. However, when the subgroup with airflow obstruction was analysed, they found that the experimental exercise programme significantly prevented a decline in both mental and physical domains of SF-36 (0.01 and 0.04, respectively). [Table 4](#table4-2050312116673855){ref-type="table"} summarises HRQoL data collected by all the included studies using SF-36.

###### 

SF-36 data.

![](10.1177_2050312116673855-table4)

                                                                                                   Reference                                    Assessment                                                    IG            CG            Between-group difference (95% CI)   p value IG-CG                                                                                                                              
  ------------------------------------------------------------------------------------------------ -------------------------------------------- ------------------------------------------------------------- ------------- ------------- ----------------------------------- ------------------------------------------------------------- --------------- ------------ --------------------- ------------------ ------ ------
  Physical domain                                                                                  Hoffman et al.^[@bibr27-2050312116673855]^   Baseline (before surgery)                                     37            48.02 ± 9.3                                                                                                     35              46.1 ± 9.2                                                   0.35
  Post-surgery                                                                                     37                                           30.2                                                                                      35                                  32.7                                                                                                             NR                        
  3 weeks post-surgery                                                                             37                                           41.5^[a](#table-fn6-2050312116673855){ref-type="table-fn"}^                               35                                  35.5^[a](#table-fn6-2050312116673855){ref-type="table-fn"}^                                                      NR                        
  6 weeks post-surgery                                                                             37                                           45.2                                                                                      35                                  38.8                                                                                                             NR                        
  Cavalheri et al.^[@bibr25-2050312116673855]^                                                     Baseline (6--10 weeks post-surgery)          9                                                             46 ± 6                      2 (−3 to 6)                         8                                                             42 ± 5                       −2 (−7 to 2)                             NR     
  8 weeks after baseline                                                                           9                                            48 ± 8                                                                      8             40 ± 9                                                                                            4 (−2 to 10)    0.20                                                         
  Edvardsen et al.^[@bibr38-2050312116673855]^                                                     Baseline (4--6 weeks post-surgery)           30                                                            48.3 ± 9                                                        31                                                            48.3 ± 11.9                                        NR                 NS     
  After PR (20 weeks)                                                                              30                                           51.8 ± 5.5                                                                                31                                  43.3 ± 11.3                                                                                0.006                                           
  Arbane et al.^[@bibr39-2050312116673855][a](#table-fn6-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery                         40                                                            17                          8.5--26.2                           38                                                            23                           10.3 to 35.8          12 (0.5--23)       0.04   
  Brocki et al.^[@bibr8-2050312116673855]^                                                         Baseline (3 weeks post-surgery)              41                                                            38.88 ± 10                                                      37                                                            38.99 ± 7                                          NR                 NR     
  4 months after baseline                                                                          32                                                                                                         6.7 ± 8                     35                                                                                                3.1 ± 9.2                    3.76 (−0.1 to 7.62)   0.06                      
  1 year after baseline                                                                            27                                                                                                         5.1 ± 11.1                  31                                                                                                7.7 ± 8.5                    −1.5 (−5.6 to 2.5)    0.27                      
  Mental domain                                                                                    Hoffman et al.^[@bibr27-2050312116673855]^   Baseline (before surgery)                                     37            48.1 ± 10.6                                                                                                     35              50 ± 10.4                                                    0.46
  Post-surgery                                                                                     37                                           51.5^[a](#table-fn6-2050312116673855){ref-type="table-fn"}^                               35                                  44.5^[a](#table-fn6-2050312116673855){ref-type="table-fn"}^                                                      NR                        
  3 weeks post-surgery                                                                             37                                           52.5^[a](#table-fn6-2050312116673855){ref-type="table-fn"}^                               35                                  47.4                                                                                                             NR                        
  6 weeks post-surgery                                                                             37                                           57.5                                                                                      35                                  47                                                                                                               NR                        
  Cavalheri et al.^[@bibr25-2050312116673855]^                                                     Baseline (6--10 weeks post-surgery)          9                                                             55 ± 6                      −4 (−12 to 5)                       8                                                             46 ± 6                       5 (−2 to 12)                             NR     
  8 weeks after baseline                                                                           9                                            51 ± 14                                                                     8             51 ± 8                                                                                            −8 (−18 to 2)   0.10                                                         
  Edvardsen et al.^[@bibr38-2050312116673855]^                                                     Baseline (4--6 weeks post-surgery)           30                                                            46.4 ± 11.1                                                     31                                                            45.4 ± 12.1                                        NR                 NS     
  After PR (20 weeks)                                                                              30                                           55.5 ± 5.3                                                                                31                                  46.6 ± 14                                                                                                        0.020                     
  Arbane et al.^[@bibr39-2050312116673855][b](#table-fn7-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery                         40                                                            2                           −11.2 to 14.3                       38                                                            15                           0.8 to 30             20 (4.6 to 34.6)   0.01   
  Brocki et al.^[@bibr8-2050312116673855]^                                                         Baseline (3 weeks post-surgery)              41                                                            45.67 ± 10                                                      37                                                            44.88 ± 9                                          NR                 NR     
  4 months after baseline                                                                          32                                                                                                         4.4 ± 10.4                  35                                                                                                5.4 ± 9.4                    −0.03 (−3.7 to 3.6)   0.99                      
  1 year after baseline                                                                            27                                                                                                         5.33 ± 8.7                  31                                                                                                9.6 ± 9                      −2.15 (−6 to 1.7)     0.27                      

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; NR: not reported; NS: not significant.

Data estimated, presented graphically.

Data refer to the subgroup with airflow obstruction.

[Appendix 3](#app3-2050312116673855){ref-type="app"} summarises detailed results for every outcome collected by the included studies in order to assess effects of experimental interventions.

Discussion {#section21-2050312116673855}
==========

This systematic review aimed at determining the best evidence-based physical exercise interventions directed at patients treated surgically for NSCLC, both pre- and post-surgery.

Regarding preoperative and postoperative PR, our review demonstrates that in this field literature is lacking a sufficient number of randomised clinical trials. Therefore, beyond the previous conclusions of Crandall et al.,^[@bibr9-2050312116673855]^ highlighting the need for further high-quality RCTs and suggesting that an optimal rehabilitation programme should include aerobic, strength and breathing exercises,^[@bibr9-2050312116673855]^ we cannot add any relevant evidence. However, our results allow us to support previous findings of Cavalheri et al.,^[@bibr16-2050312116673855]^ suggesting inclusion of exercise training in PR programmes after lung resection for NSCLC.^[@bibr16-2050312116673855]^

Preoperative PR {#section22-2050312116673855}
---------------

Concerning the effects of exercise training for people undergoing lung resection, we found only one RCT published in the last 2 years.^[@bibr37-2050312116673855]^ Moreover, findings of this study should be analysed with caution due to questionable methodologic quality, since randomisation method was not clearly described and attrition and reporting biases are likely to have affected results. Furthermore, the authors did not provide any information about blinding of assessors. However, outcomes measured in this study were instrumentally determined by precise guidelines, consequently blinding of assessors may not have been so essential. Regarding exercise-training programme, this trial followed current physical activity guidelines for PR in cancer patients (2--4 weeks, 5 times/week).^[@bibr10-2050312116673855]^ This training modality is feasible, although its efficacy has not yet been clearly confirmed by large sample size studies.^[@bibr10-2050312116673855]^ The trial of Stefanelli et al.^[@bibr37-2050312116673855]^ exhibited a beneficial effect of preoperative PR on physical performance in patients with COPD and NSCLC, even if no improvements in lung function were revealed. This result should be interpreted in light of the fact that exercise training was associated with significant increase in VO~2peak~, as confirmed by previous studies.^[@bibr40-2050312116673855],[@bibr41-2050312116673855]^ Also, it is well documented that cardiorespiratory fitness is a strong independent predictor of postoperative complications and survival in NSCLC patients after lung resection.^[@bibr15-2050312116673855],[@bibr42-2050312116673855],[@bibr43-2050312116673855]^ So, even if Stefanelli et al.^[@bibr37-2050312116673855]^ did not assess PPCs, we may infer that preoperative PR could reduce postoperative respiratory morbidity, length of hospital stay and health-care costs due to improvements in cardiorespiratory fitness induced by enhanced physical performance.^[@bibr44-2050312116673855],[@bibr45-2050312116673855]^

Even though our research focused mainly on exercise training, we noticed that preoperative PR programmes often integrate a respiratory component, which frequently includes IMT.^[@bibr44-2050312116673855],[@bibr45-2050312116673855]^ Indeed, a previous meta-analysis concluded that preoperative IMT significantly improves respiratory muscle function.^[@bibr46-2050312116673855]^ Hence, we suggest including this specific component in preoperative PR programmes.

Postoperative PR {#section23-2050312116673855}
----------------

Regarding postoperative PR, the five RCTs included in our review showed a good methodologic quality.^[@bibr8-2050312116673855],[@bibr25-2050312116673855],[@bibr27-2050312116673855],[@bibr38-2050312116673855],[@bibr39-2050312116673855]^ These five studies were classified at low risk of bias for almost every parameter, except for the risk of performance bias. However, it is necessary to point out that, in the rehabilitation field, it is very difficult to guarantee participant and personnel blinding. For this reason, it is critically important to assure blinding of outcome assessors, as seen in four^[@bibr8-2050312116673855],[@bibr25-2050312116673855],[@bibr38-2050312116673855],[@bibr39-2050312116673855]^ out of five^[@bibr27-2050312116673855]^ studies included in our review.

Concerning the effect of postoperative PR on physical capacity, the variability in PR programmes and outcome measures applied in the included studies prevented us from adding any relevant evidence to the previous systematic reviews.^[@bibr9-2050312116673855],[@bibr16-2050312116673855]^ One of the included studies showed beneficial effects on cardiorespiratory fitness after supervised endurance and strength training, measured by VO~2peak~^[@bibr38-2050312116673855]^ and another one^[@bibr27-2050312116673855]^ showed an increase in the walking distance up to preoperative levels. Another study showed beneficial effects in both CPET and 6MWT.^[@bibr25-2050312116673855]^ These results are in accordance with the meta-analyses performed by Cavalheri et al.,^[@bibr16-2050312116673855]^ supporting increase in physical capacity through exercise training in this population. Conversely, the other two trials^[@bibr8-2050312116673855],[@bibr39-2050312116673855]^ revealed no differences between groups for physical capacity, with similar increases in walking distance and recovery up to preoperative functional levels in both groups. However, the results of Arbane et al.^[@bibr39-2050312116673855]^ should be considered with caution, since this study reported high number of lost to follow-up patients (27% in CG and 17% in IG); so, the risks of attrition bias and type II error cannot be entirely excluded. Regarding the trial of Brocki et al.,^[@bibr8-2050312116673855]^ it is important to point out that some form of physical training was included in both IG and CG. Indeed, the authors intended to compare supervised versus unsupervised exercise training and outpatient versus home-based settings. Their results were not statistically significant but tended to show a slightly faster recovery through supervised exercise.

Concerning pulmonary function, our review does not demonstrate any changes after postoperative PR programmes, in accordance with Crandall et al.^[@bibr9-2050312116673855]^ and Cavalheri et al.^[@bibr16-2050312116673855]^ reviews and with previous research conducted on COPD patients.^[@bibr47-2050312116673855]^

Regarding HRQoL, our review suggests that exercise training could be advantageous. Even if results were not exactly identical in the included trials, four^[@bibr8-2050312116673855],[@bibr27-2050312116673855],[@bibr38-2050312116673855],[@bibr39-2050312116673855]^ out of five^[@bibr25-2050312116673855]^ studies reported a certain degree of change in HRQoL using SF-36, always favouring IG. Certainly, there is still little evidence concerning the effects of exercise training on HRQoL, as also observed by Crandall et al.^[@bibr9-2050312116673855]^ and Cavalheri et al.^[@bibr16-2050312116673855]^ In addition, it has been shown that lung resection for NSCLC has a greater detrimental impact on quality of life compared to other major visceral surgeries.^[@bibr4-2050312116673855]^ Perhaps for this reason, research in this field has started to focus not only on functional outcome measures but also on quality of life as perceived by patients. Although NSCLC survivors are extremely vulnerable and, consequently, need time to recover from treatment,^[@bibr4-2050312116673855]^ there is now a growing body of evidence regarding this topic. Possibly, more prolonged treatments over time may have more decisive effects on this outcome.

The five postoperative trials included in our review presented various forms of PR programmes. They were similar only in one type of exercise included (aerobic), but each study also added different kinds of training (strength or balance) and they also differed in setting, session duration, intensity, length of intervention and frequency. These dissimilarities made it difficult to identify the best exercise intervention design. Even if it was not possible to establish the best evidence-based physical exercise intervention, previous studies support the inclusion of aerobic exercise training combined with other forms of exercise,^[@bibr11-2050312116673855],[@bibr31-2050312116673855]^ such as strength training, as suggested by recent guidelines^[@bibr10-2050312116673855]^ and systematic reviews^[@bibr9-2050312116673855],[@bibr48-2050312116673855]^ on optimal perioperative PR programmes for lung cancer patients. Considering that the majority of patients affected by lung cancer also present COPD,^[@bibr3-2050312116673855]^ exercise-training programmes specific for this population are often based on COPD training programmes and are frequently associated with a respiratory component. This component is usually made up of IMT,^[@bibr12-2050312116673855],[@bibr38-2050312116673855]^ incentive spirometry,^[@bibr49-2050312116673855]^ airway clearance techniques^[@bibr39-2050312116673855]^ and respiratory exercises.^[@bibr19-2050312116673855]^

Regarding location of exercise intervention, there is no evidence that allows us to indicate the best setting or any other features of rehabilitation programmes. In any case, a recent review by Maguire et al.^[@bibr50-2050312116673855]^ analysed needs of people living with lung cancer and highlighted the importance of addressing fatigue, dyspnoea, pain, difficulties in daily activities, psychological distress and return to work issues. These domains should be included in any rehabilitation programme. Moreover, educational sessions would be useful in order to empower people to cope better with their disease. This review also pointed out difficulties in accessibility to health-care programmes due to transportation problems. Therefore, when defining and choosing an intervention programme, it is of utmost importance to consider patient needs and availability of local health-care services. Thus, the best PR programme would probably reflect a combination of supervised outpatient and unsupervised home-based training. Furthermore, bearing in mind the psychological condition of NSCLC patients, the inclusion of group sessions might be beneficial for sharing experiences and facilitating social domain.^[@bibr51-2050312116673855]^ Supporting this theme, a study conducted by Swenson et al.^[@bibr52-2050312116673855]^ reported that patients attending group sessions were more likely to complete the programme. Furthermore, the authors declare that group setting was acceptable and beneficial for this population.^[@bibr52-2050312116673855]^

Recent literature has demonstrated that either pre- or post-operative exercise training for NSCLC patients is safe, feasible and acceptable.^[@bibr7-2050312116673855],[@bibr9-2050312116673855],[@bibr13-2050312116673855]^ In our review, none of the included studies reported data regarding safety of the applied intervention. In all, 96 of the 374 patients randomised dropped out. Surely, a drop-out rate of 26% might indicate limited acceptability or feasibility, although in this population a similar rate of withdrawal might be considered normal, as also reported by a recent study of Sommer et al.^[@bibr28-2050312116673855]^ Nevertheless, the majority of patients lost to follow-up were found in only one study^[@bibr39-2050312116673855]^ and the reason for this drop-out rate concerned, in most cases, loss of inclusion criteria.

This review has some limitations. First, we only analysed the last 3 years of published literature; however, we choose not to search for older publications because two extensive and well-done systematic review had been published in recent years.^[@bibr9-2050312116673855],[@bibr16-2050312116673855]^ Second, although we only focused on collecting evidence regarding exercise training programmes, we recognise that other rehabilitation interventions (i.e. chest physiotherapy, educational or psychological programmes, nutritional interventions) might be beneficial in this population. Finally, the clinical trials included in this review showed different quality levels and were not completely free of risk of bias, although we know that a certain risk of bias may almost always be present in studies conducted in the field of rehabilitation. Regardless of different quality levels of evidence, this review suggests that inclusion of exercise-training programmes should be considered for this population, both pre- and post-surgery. In particular, exercise training may have an important role for patients that already have compromised functional capacity or present comorbidities, such as COPD.^[@bibr9-2050312116673855],[@bibr11-2050312116673855],[@bibr16-2050312116673855],[@bibr53-2050312116673855]^

In conclusion, this review has shown that, because of insufficient number of RCTs and substantial heterogeneity between types of interventions, it is not possible to establish the best exercise intervention programme, either pre- or post-surgery, for patients surgically treated for NSCLC. Nevertheless, this review further emphasises the complexity of PR for this population. Interventions often include several interacting components such as exercise training, IMT, incentive spirometry, airway clearance techniques and respiratory exercise. This systematic review highlights the urgent need for additional and larger RCTs with better methodology, in order to collect stronger evidence and clarify the role of exercise-training programmes for these patients. Finally, we should highlight the value of both pre- and post-surgery physical training programmes, implemented in a multidisciplinary environment, that include aerobic training as the most relevant component to improve exercise capacity.

Clinical messages {#section24-2050312116673855}
=================

-   Urgent need for additional and larger RCTs with better methodological quality in order to identify the best physical exercise interventions design for surgically treated NSCLC patients.

-   Literature suggests inclusion of both aerobic and strength training in an optimal perioperative PR programme.
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  ------ ------------------------------------------------------
  S1.    exp Lung Neoplasms/
  S2.    lung cancer.mp.
  S3.    lung neoplasm\*.mp.
  S4.    Non-Small-Cell Lung.mp.
  S5.    1 or 2 or 3 or 4
  S6.    exp Exercise/
  S7.    exp Exercise Therapy/
  S8.    exp Physical Fitness/
  S9.    exp Rehabilitation/
  S10.   exp Physical Therapy Modalities/
  S11.   exercise.mp.
  S12.   physical activity.mp.
  S13.   physical fitness.mp.
  S14.   rehabilitation.mp.
  S15.   exercise therapy.mp.
  S16.   6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15
  S17.   exp General Surgery/
  S18.   exp Pulmonary Surgical Procedures/
  S19.   exp Thoracic Surgical Procedures/
  S20.   exp Surgical Procedures, Operative/
  S21.   surg\*.mp.
  S22.   operat\*.mp.
  S23.   resection.mp.
  S24.   lobectomy.mp.
  S25.   17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
  S26.   5 and 16 and 25
  S27.   remove duplicates from 26
  ------ ------------------------------------------------------

Note that the suffix exp = exploded term, / = MeSH and mp. = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept and unique identifier (free-text term).

Risk of bias analysis {#section26-2050312116673855}
=====================
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  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Item                                                               Authors' judgement   Description
  ------------------------------------------------------------------ -------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Preoperative: Stefanelli et al.** ^[@bibr37-2050312116673855]^                        

  Sequence generation                                                Unclear              Quote: 'Patients were randomly assigned to two groups'\
                                                                                          Comment: insufficient to be confident that the allocation sequence was genuinely randomised

  Allocation concealment                                             Unclear              Quote: 'Patients were randomly assigned to two groups'\
                                                                                          Comment: probably not done, no information about the allocation concealment

  Blinding of participants and personnel                             High risk            Open label

  Blinding of outcome assessment                                     Low risk             Comment: blinding of outcome assessment is not reported but the outcomes considered in our review (VO2 peak, FEV~1~, FVC, DLCO) are not likely to be influenced by lack of blinding

  Incomplete outcome data                                            High risk            No defined number of patients at the follow-up

  Selective reporting                                                High risk            FVC data not reported

  Other bias                                                         High risk            Number of patients in IG and CG are not reported

  **Postoperative: Hoffman et al.** ^[@bibr27-2050312116673855]^                          

  Sequence generation                                                Low risk             Quote: 'A random-number table was generated by the team statistician to identify whether the potential participant was assigned to the IG or CG. The random-number table included decimal numbers between 0 and 1'.

  Allocation concealment                                             Low risk             Quote: 'The random allocation was a predefined assigned slot when a patient enrolled in the study. The recruiter used the next available predefined slot for allocation'

  Blinding of participants and personnel                             High risk            Open label

  Blinding of outcome assessment                                     Low risk             Assessors were not blinded to patient's group allocation but outcomes considered in this study and extracted for our review (6MWT, SF-36) are not likely to be influenced by lack of blinding

  Incomplete outcome data                                            Low risk             Quote: 'All analyses were completed on the randomized groups by intent to treat'

  Selective reporting                                                High risk            6MWT and SF-36 data are reported incompletely

  Other bias                                                         Low risk             Study appears to be free of other sources of bias

  **Postoperative: Cavalheri et al.** ^[@bibr25-2050312116673855]^                        

  Sequence generation                                                Low risk             Quote: 'The randomisation sequence was generated and managed by an independent researcher using a computer ...'

  Allocation concealment                                             Low risk             Quote: '... and concealed using sequentially numbered opaque envelopes'

  Blinding of participants and personnel                             High risk            Open label

  Blinding of outcome assessment                                     Low risk             Assessors were blinded to patient's group allocation.

  Incomplete outcome data                                            Low risk             Quote: 'Analyses were undertaken according to the intention-to-treat principle'

  Selective reporting                                                Low risk             All pre-specified outcomes were reported

  Other bias                                                         Low risk             Study appears to be free of other sources of bias

  **Postoperative: Edvardsen et al.** ^[@bibr38-2050312116673855]^                        

  Sequence generation                                                Low risk             Quote: 'The randomisation was done in blocks with varying block size (4--6 subjects)'

  Allocation concealment                                             Low risk             Quote: '... put into sealed opaque envelopes generated by an external statistician'

  Blinding of participants and personnel                             High risk            Open label

  Blinding of outcome assessment                                     Low risk             Quote: '... single-blind single-centre randomised controlled trial'; '... we cannot rule out the possibility that the technicians were not blinded during the last data collection'\
                                                                                          Comment: outcomes considered in this study and extracted for our review (VO2peak, FEV~1~, SF-36, EORTC) are not likely to be influenced by lack of blinding

  Incomplete outcome data                                            Low risk             Missing data have been imputed using intention-to-treat analysis

  Selective reporting                                                Low risk             All pre-specified outcomes were reported

  Other bias                                                         Low risk             Study appears to be free of other sources of bias

  **Postoperative: Arbane et al.** ^[@bibr39-2050312116673855]^                           

  Sequence generation                                                Low risk             Quote: 'The randomisation sequence was created using StataVersion 9.0 (StataCorp, College Station, TX, USA) and was stratified by centre with a 1:1 allocation using random block sizes of two, 4 and six. ... The online randomisation service provided by the Mental Health and Neurosciences Clinical Trials Unit supplied by King's College London'

  Allocation concealment                                             Low risk             Quote: 'The allocation sequence was concealed from the researcher who enrolled and assessed the participants. ... This prevent foreknowledge of treatment assignment, and thus shielded those who recruited participants from being influenced by this knowledge'

  Blinding of participants and personnel                             High risk            Quote: 'The study was open labelled; neither the participants nor the researchers were blinded'.

  Blinding of outcome assessment                                     Low risk             The allocation sequence was concealed from the researcher who enrolled and assessed the participants

  Incomplete outcome data                                            Low risk             Missing data have been imputed using appropriate methods

  Selective reporting                                                High risk            Shuttle walk test and EORTC data are reported incompletely

  Other bias                                                         Low risk             The study appears to be free of other sources of bias

  **Postoperative: Brocki et al.** ^[@bibr8-2050312116673855]^                            

  Sequence generation                                                Low risk             Quote: 'Computer-generated randomization tables, stratified for pneumonectomy (expected low performance status) were used'.

  Allocation concealment                                             Low risk             Quote: 'Individual allocations were placed in consecutively numbered and sealed opaque envelopes by an external person'

  Blinding of participants and personnel                             High risk            Open label

  Blinding of outcome assessment                                     Low risk             Assessors were blinded to the patient's group allocation

  Incomplete outcome data                                            Low risk             Analyses were based on an intention-to-treat approach, assuming that each individual adhered to their assigned treatment at each time point

  Selective reporting                                                Low risk             All pre-specified outcomes were reported

  Other bias                                                         Low risk             The study appears to be free of other sources of bias
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FEV~1~: forced expiratory volume in first second; DLCO: diffusing lung capacity of carbon monoxide; FVC: functional vital capacity; IG: intervention group; CG: control group; 6MWT: Six-Minute Walk Test; SF-36: Short Form 36; EORTC: European Organisation for Research and Treatment of Cancer.

Results of the studies selected {#section27-2050312116673855}
===============================

Preoperative PR {#section28-2050312116673855}
---------------

### Exercise capacity {#section29-2050312116673855}

![](10.1177_2050312116673855-table7)

  Reference -- exercise capacity                                            Assessment   IG                  CG           p value IG-CG                                         
  ------------------------------------------------------------------------- ------------ ------------------- ------------ -------------------------- -------- ------------ ---- ----
  Stefanelli et al.^[@bibr37-2050312116673855]^ -- VO~2~ peak (mL/kg/min)   Baseline     NR                  14.9 ± 2.3   \<0.001                    NR       14.8 ± 1.4   NS   NS
  Before surgery                                                            17.8 ± 2.1   14.5 ± 1.2          \<0.001                                                            
  60 days post-surgery                                                      15.1 ± 2.4   \<0.001 versus T1   11.4 ± 1.2   \<0.001 versus T0 and T1   \<0.01                     

IG: intervention group; CG: control group; SD: standard deviation; NS: not significant; NR: not reported.

Postoperative PR {#section30-2050312116673855}
----------------

### Exercise capacity {#section31-2050312116673855}

![](10.1177_2050312116673855-table8)

  Reference -- exercise capacity                                           Assessment                                                                       IG                                    CG                                                                  Between-group difference (95% CI)   p value IG-CG                                                                                                                                                           
  ------------------------------------------------------------------------ -------------------------------------------------------------------------------- ------------------------------------- ------------------------------------------------------------------- ----------------------------------- --------------- ---------------------- ------------------------------------------------------------------- ------------ ---------------- ----------------------- ------ ----
  Hoffman et al.^[@bibr27-2050312116673855]^ -- 6MWT                       Baseline (before surgery)                                                        37                                                                                                        365 ± 91                            NR              35                                                                                         407 ± 64     NR                                       0.03   
  Post-study (6 weeks post-surgery)                                        37                                                                                                                     +15% (SD, 15%)                                                      35                                                  −21% (SD, 19%)                                                                             \<0.001                                                      
  Cavalheri et al.^[@bibr25-2050312116673855]^                             VO~2\ peak~ (L/min)                                                              Baseline (6--10 weeks post-surgery)   6                                                                                                       0.96 ± 0.22     0.14 (−0.01 to 0.28)   8                                                                                1.08 ± 0.40      −0.05 (−0.15 to 0.05)          NR
  8 weeks after baseline                                                   6                                                                                                                      1.96 ± 0.28                                                         8                                                   1.03 ± 0.30            0.2 (0.03 to 0.33)                                                  0.02                                                         
  6MWT (m)                                                                 Baseline (6--10 weeks post-surgery)                                              6                                                                                                         540 ± 71                            45 (6 to 83)    8                                                                                          477 ± 78     −8 (−36 to 20)                           NR     
  8 weeks after baseline                                                   6                                                                                                                      585 ± 77                                                            8                                                   496 ± 105              52 (12 to 93)                                                       0.02                                                         
  Edvardsen et al.^[@bibr38-2050312116673855]^ -- VO~2~ peak (mL/kg/min)   Baseline (4--6 weeks post-surgery)                                               30                                                                                                        19.2 ± 5.1                          NR              31                                                                                         18.1 ± 5.5   NR               NR                      NR     
  After PR (20 weeks)                                                      30                                                                                                                     23.3 ± 5.5                                                          31                                                  19 ± 6                 3.4 (1.3 to 5.5)                                                    2                                                            
  Brocki et al.^[@bibr8-2050312116673855]^ -- 6MWT (m)                     Baseline (3 weeks post-surgery)                                                  41                                    427^[a](#table-fn12-2050312116673855){ref-type="table-fn"}^ ± 124                                       NR              37                     407^[a](#table-fn12-2050312116673855){ref-type="table-fn"}^ ± 102                NR               NR                      NR     
  4 months after baseline                                                  32                                                                               +61 ± 52                                                                                                  34                                  +55 ± 45                               8.33 (−20 to 36.27)                                                 0.57                                                         
  1 year after baseline                                                    27                                                                               +65 ± 70                                                                                                  29                                  +60 ± 45                               1.31 (−28.18 to 30.8)                                               0.93                                                         
  Arbane et al.^[@bibr39-2050312116673855]^ -- ISWT                        Arbane et al. did not report exercise capacity levels measured by ISWT clearly                                                                                                                                                                                                                                                                                                                         

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; 6MWT: Six-Minute Walk Test; ISWT: Incremental Shuttle Walk Test; NR: not reported.

Mean.

HRQoL {#section32-2050312116673855}
-----

### SF-36 {#section33-2050312116673855}

![](10.1177_2050312116673855-table9)

  Physical domain                            Reference                                                                                         Assessment             IG           CG   Between-group difference (95% CI)   p value IG-CG                                                               
  ------------------------------------------ ------------------------------------------------------------------------------------------------- ---------------------- ------------ ---- ----------------------------------- --------------- ------------------------ -------------- ------------------- ------
  Physical functioning                       Arbane et al.^[@bibr39-2050312116673855][a](#table-fn14-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery   40           9    −3.8 to 22                          38              24                       10.5 to 36.8   18 (3 to 32.4)      0.02
  Brocki et al.^[@bibr8-2050312116673855]^   Baseline (3 weeks post-surgery)                                                                   41                     60.37 ± 25        37                                  59.05 ± 23                               NR             NR                  
  4 months after baseline                    32                                                                                                8.4 ± 21.3                          35   6.4 ± 20.1                                          4.39 (−4 to 12.8)        0.3                                
  1 year after baseline                      27                                                                                                4.8 ± 24.3                          31   14.5 ± 20.3                                         −4.87 (−13.7 to 4)       0.28                               
  Role-physical                              Arbane et al.^[@bibr39-2050312116673855][a](#table-fn14-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery   40           32   6.7 to 56.9                         38              43                       13.8 to 72.8   24 (−3.8 to 52.7)   0.13
  Brocki et al.^[@bibr8-2050312116673855]^   Baseline (3 weeks post-surgery)                                                                   41                     31.7 ± 29         37                                  36.66 ± 24                               NR             NR                  
  4 months after baseline                    32                                                                                                28.1 ± 33.8                         35   15 ± 27.2                                           12.04 (−1 to 25.1)       0.07                               
  1 year after baseline                      27                                                                                                26.4 ± 42.3                         31   34.9 ± 26                                           −6.93 (−20.7 to 6.99)    0.33                               
  Bodily pain                                Arbane et al.^[@bibr39-2050312116673855][a](#table-fn14-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery   40           28   13.9 to 41.7                        38              28                       12.6 to 42.7   3 (−13.3 to 19.5)   0.69
  Brocki et al.^[@bibr8-2050312116673855]^   Baseline (3 weeks post-surgery)                                                                   41                     45.83 ± 28        37                                  45.51 ± 24                               NR             NR                  
  4 months after baseline                    32                                                                                                30.3 ± 24.9                         35   15.3 ± 34.2                                         15.3 (4 to 26.6)         0.01                               
  1 year after baseline                      27                                                                                                28.4 ± 24.5                         31   30.8 ± 33.7                                         4.32 (−7.8 to 16.5)      0.49                               
  General health                             Arbane et al.^[@bibr39-2050312116673855][a](#table-fn14-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery   40           7    0 to 13.6                           38              1                        −11.4 to 4.2   −4 (−16.6 to 9.6)   0.85
  Brocki et al.^[@bibr8-2050312116673855]^   Baseline (3 weeks post-surgery)                                                                   41                     68.32 ± 21        37                                  66.38 ± 19                               NR             NR                  
  4 months after baseline                    32                                                                                                −1.88 ± 18.7                        35   1.1 ± 12.9                                          −2.64 (−10.11 to 4.9)    0.49                               
  1 year after baseline                      27                                                                                                −2.81 ± 19                          31   7.74 ± 15.3                                         −10.34 (−18.3 to −2.4)   0.01                               

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; NR: not reported.

Data refer to the subgroup with airflow obstruction.

![](10.1177_2050312116673855-table10)

  Mental domain                              Reference                                                                                         Assessment             IG           CG   Between-group difference (95% CI)   p value IG-CG                                                              
  ------------------------------------------ ------------------------------------------------------------------------------------------------- ---------------------- ------------ ---- ----------------------------------- --------------- ----------------------- -------------- ------------------- ------
  Vitality                                   Arbane et al.^[@bibr39-2050312116673855][a](#table-fn16-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery   40           12   0 to 24.6                           38              13                      1.9 to 23.4    7 (−5.1 to 18.3)    0.26
  Brocki et al.^[@bibr8-2050312116673855]^   Baseline (3 weeks post-surgery)                                                                   41                     46.46 ± 18        37                                  43.24 ± 16                              NR             NR                  
  4 months after baseline                    32                                                                                                15.94 ± 20                          35   14.1 ± 15                                           4.65 (−2.98 to 12.3)    0.23                               
  1 year after baseline                      27                                                                                                12 ± 24.2                           31   22.2 ± 15                                           −8.48 (−16.4 to −0.6)   0.04                               
  Social functioning                         Arbane et al.^[@bibr39-2050312116673855][a](#table-fn16-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery   40           2    −17 to 21.5                         38              10                      −10 to 30      18 (−5.5 to 41)     0.13
  Brocki et al.^[@bibr8-2050312116673855]^   Baseline (3 weeks post-surgery)                                                                   41                     73.78 ± 27        37                                  73.65 ± 30                              NR             NR                  
  4 months after baseline                    32                                                                                                13.3 ± 24.4                         35   9.3 ± 31.9                                          3.7 (−5.8 to 13.2)      0.44                               
  1 year after baseline                      27                                                                                                14.81 ± 27.5                        31   19.35 ± 26.8                                        −2.01 (−12 to 7.8)      0.67                               
  Role-emotional                             Arbane et al.^[@bibr39-2050312116673855][a](#table-fn16-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery   40           3    −40.6 to 34.5                       38              42                      0.1 to 84.3    45 (−0.2 to 89.2)   0.05
  Brocki et al.^[@bibr8-2050312116673855]^   Baseline (3 weeks post-surgery)                                                                   41                     56.91 ± 36        37                                  53.6 ± 33                               NR             NR                  
  4 months after baseline                    32                                                                                                12.5 ± 43.4                         35   20.7 ± 31.5                                         −11.93 (−14 to 10.1)    0.75                               
  1 year after baseline                      27                                                                                                21 ± 41.4                           31   36.81 ± 35                                          3.39 (−16.3 to 9.5)     0.61                               
  Mental health                              Arbane et al.^[@bibr39-2050312116673855][a](#table-fn16-2050312116673855){ref-type="table-fn"}^   4 weeks post-surgery   40           −8   −15.5 to −0.5                       38              2                       −9.3 to 13.6   8 (−3.3 to 18.5)    0.16
  Brocki et al.^[@bibr8-2050312116673855]^   Baseline (3 weeks post-surgery)                                                                   41                     60.76 ± 18        37                                  60.97 ± 17                              NR             NR                  
  4 months after baseline                    32                                                                                                9 ± 18.9                            35   6.6 ± 19.3                                          3.77 (−2.7 to 110.2)    0.25                               
  1 year after baseline                      27                                                                                                7.6 ± 13.3                          31   14.8 ± 16.2                                         −3.6 (−10.4 to 3.2)     0.3                                

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; NR: not reported.

Data refer to the subgroup with airflow obstruction.

EORTC {#section34-2050312116673855}
-----

Arbane et al.^[@bibr39-2050312116673855]^ -- 'no significant differences were found between the groups using EORTC QLQ-LC13'.

Edvardsen et al.^[@bibr38-2050312116673855]^

![](10.1177_2050312116673855-table11)

                        Assessment                           IG   CG     p value IG-CG                      
  --------------------- ------------------------------------ ---- ------ --------------- ---- ------ ------ ----
  Dyspnoea              Baseline (4--6 weeks post-surgery)   30   33.3   NR              31   33.3   NR     NS
  After PR (20 weeks)   30                                   37   25.3   31              58   32.1   0.03   

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; NR: not reported; NS: not significant; NR: not reported.
